‘The craving is just not there’: How Ozempic is affecting snacking culture
A survey published Tuesday by Dalhousie University, Halifax, estimates that between 900,000 and 1.4 million Canadians use GLP-1 receptor agonists.
A survey published Tuesday by Dalhousie University, Halifax, estimates that between 900,000 and 1.4 million Canadians use GLP-1 receptor agonists.
